© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Multiple Sclerosis
The NeurologyLive multiple sclerosis (MS) clinical focus page offers information, podcasts, videos, and news about the latest study and clinical trial findings, FDA actions, clinical guideline updates, and expert interviews related to the care and management of patients with MS, including relapsing MS and progressive MS, as well as related disorders such as neuromyelitis optica spectrum disorder.
This Week on NeurologyLive — June 14, 2021
June 14, 2021
Article
Here's what is coming soon to NeurologyLive.
NeurologyLive Friday 5 — June 11, 2021
June 11, 2021
Article
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 11, 2021.
Future Direction of MS Treatment
June 10, 2021
Video
Key opinion leaders in neurology, Lawrence Steinman, MD and Enrique Alvarez, MD, PhD, reflect on future developments in the management of multiple sclerosis and share key advice for community physicians.
Evobrutinib in MS: The EVOLUTION RMS I and II Trials
June 10, 2021
Video
Thought leaders in neurology consider the role of BTK inhibitors such as evobrutinib and review the potential impact on patients with progressive multiple sclerosis.
Best Strategies for Controlling Relapsing-Remitting MS
June 07, 2021
Video
Drs Patricia K. Coyle and Robert Fox comment on approaching multiple sclerosis relapses as early as possible with high-efficacy therapy.
Treating Relapsing-Remitting MS: Switching Therapy
June 07, 2021
Video
Factors that may warrant a switch in therapy to treat relapsing-remitting multiple sclerosis.
This Week on NeurologyLive — June 7, 2021
June 07, 2021
Article
Here's what is coming soon to NeurologyLive.
NeurologyLive Friday 5 — June 4, 2021
June 04, 2021
Article
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 4, 2021.
ATA188’s Potential in Progressive MS: Jakob Dupont, MD, MA
June 02, 2021
Video
The head of global research and executive vice president of Atara Biotherapeutics discussed improvements seen in patients treated with the investigational therapy.
Developing the aT2-LV Biomarker for Progressive MS
June 02, 2021
Article
Robert Zivadinov, MD, PhD, professor of neurology and director of the Buffalo Neuroimaging Analysis Center, discussed the post-hoc analysis of the ORATORIO trial he and colleagues conducted.